Registration Frequencies

Fig 1) Patient numbers by biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 1) Patient numbers by biologic treatment at inclusion

 

Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion
Last update: | n= | updated weekly
Fig 2) PsoBest registry: patient numbers by non-biologic treatment at inclusion

 

Show table for Fig. 1/2Hide table

Inclusion Treatment Patient Number of that with similar agents (e.g. Biosimilars)
Adalimumab 981 134
Brodalumab 199 0
Certolizumab 53 0
Efalizumab 35 0
Etanercept 304 49
Golimumab 26 0
Guselkumab 378 0
Infliximab 101 1
Ixekizumab 322 0
Risankizumab 72 0
Secukinumab 1105 0
Tildrakizumab 98 0
Ustekinumab 669 0
Apremilast 426 0
Ciclosporin 372 0
Fumaderm 2567 0
Skilarence 1173 0
Methotrexate 2762 0
other systemics 317 0

 

Fig. 3) Rate of patients by medication class at inclusion
Last update: | n= | updated weekly
Fig. 3) Rate of patients by medication class at inclusion

 

Fig. 4) Rate of patients by type of registry site
Last update: | n= | updated weekly
Fig. 4) Rate of patients by type of registry site

 

Fig. 5) Registered PsoBest centers
Last update: | n= | updated monthly
Fig. 5) Registered PsoBest centers